drugset / Trial / NCT00664703
Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult Patients
Phase 2
Completed
13 enrolled
Yaupon Therapeutics
National Institute of Mental Health (NIMH) · collab
RandomizedFactorialDouble-blindTreatment
Summary
The study will evaluate the effectiveness of the nonstimulant medication lobeline in improving symptoms of attention deficit hyperactivity disorder in adults.
Timeline
- Start
- 2008-07
- Primary completion
- 2010-01
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lobeline | Small molecule | 7.5 mg | Other |
| Subject | Lobeline | Small molecule | 15 mg | Other |
| Subject | Lobeline | Small molecule | 30 mg | Other |
| Comparator | Methylphenidate | Small molecule | 15 mg | — |
| Comparator | Methylphenidate | Small molecule | 30 mg | — |